New England Journal of Medicine

Vol. 392, Issue 1 Issue 1 2025
20
Articles

Articles in this Issue

More on Selpercatinib and Pseudo-Decreases in Kidney Function

Jan 02, 2025 pp. 103-104 10.1056/nejmc2413668

Checkpoint Immunotherapy for Melanoma — Offering Hope for Cure

Brendan D. Curti Jan 02, 2025 pp. 81-82 10.1056/nejme2412226

Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs

Galo A. Goig, Chloé Loiseau, Nino Maghradze et al. Jan 02, 2025 pp. 97-99 10.1056/nejmc2404644

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion-Sileni, Piotr Rutkowski et al. Jan 02, 2025 pp. 11-22 10.1056/nejmoa2407417

Leveraging Old Hepatitis C Therapies

S. Sean Tu, Shyamasundaran Kottilil, T. Joseph Mattingly Jan 02, 2025 pp. 1-4 10.1056/nejmp2409842

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

Andrea B. Apolo, Karla V. Ballman, Guru Sonpavde et al. Jan 02, 2025 pp. 45-55 10.1056/nejmoa2401726

Vutrisiran for ATTR Amyloidosis with Cardiomyopathy

Giampaolo Merlini Jan 02, 2025 pp. 83-84 10.1056/nejme2411602

NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

Eric J. Rubin, Oladapo O. Yeku, Stephen Morrissey Jan 02, 2025 10.1056/nejme2411485

Long-Acting HIV Medicines and the Pandemic Inequality Cycle — Rethinking Access

Winnie Byanyima, Linda-Gail Bekker, Matthew M. Kavanagh Jan 02, 2025 pp. 90-96 10.1056/nejmms2412286

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

Jan 02, 2025 pp. 101-102 10.1056/nejmc2414269

When Blurry Vision Clouds the Bigger Picture

Rohan Khazanchi, Patricia A. Stoeck, Ryan Gise et al. Jan 02, 2025 pp. 73-79 10.1056/nejmcps2402327

Chronic Myeloid Leukemia with Hyperleukocytosis

Bashir A. Bashir Jan 02, 2025 pp. 72-72 10.1056/nejmicm2402918

NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

Eric J. Rubin, Oladapo O. Yeku, Stephen Morrissey Jan 02, 2025 10.1056/nejme2411489

NEJM at ESC — Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

Eric J. Rubin, Jane Leopold, Stephen Morrissey Jan 02, 2025 10.1056/nejme2410890

Miles to Go and Nowhere to Sleep

Heather Kovich Jan 02, 2025 pp. 7-9 10.1056/nejmp2405627

Congenital Spinal Meningocele

Tariq Parker, Kristopher T. Kahle Jan 02, 2025 10.1056/nejmicm2410556

Westermark’s Sign and Palla’s Sign in Pulmonary Embolism

Yuichiro Shimoyama, Yoshitaka Tomoda Jan 02, 2025 10.1056/nejmicm2409241

When Diversity Goals Meet Multiregional Trials

Gautam U. Mehta, Richard Pazdur, Namandjé N. Bumpus et al. Jan 02, 2025 pp. 4-7 10.1056/nejmp2409392

NEJM at ESC — Asundexian versus Apixaban in Patients with Atrial Fibrillation

Eric J. Rubin, Jane Leopold, Stephen Morrissey Jan 02, 2025 10.1056/nejme2410902

Transitional Justice — A Politico-Legal Approach to Health Equity

Emily McNeill, Hetty Cunningham, Maya Sabatello Jan 02, 2025 pp. 85-89 10.1056/nejmms2408222

All Issues

Journal Info

Publisher Massachusetts Medical Society
ISSN 0028-4793
E-ISSN 0096-6762
Subject Social Sciences
Language English
View Full Journal Page